glp 1 or glp 2 what's the difference between and GLP-1-based therapies: current knowledge of differences between native GLP-1 vs. GLP-2 vs. GLP-3:

The drug, called Foundayo, resulted in an average of 27 pounds lost in 72 weeks Weight loss was just the beginning: How the GLP-1 story is evolving Imitation drugs, unexpected benefits, serious pitfallsheres what comes next as GLP-1 medications continue to rise in popularity Ozempic and other new diabetes drugs revolutionize kidney treatment Three types of diabetes medication are improving the outlook for patients with kidney disease

Mather K, et al

CrossRef Adipose Tissue Dysfunction and Hepatic Steatosis in New-Onset Diabetes Emilia Rusu, Mariana Jinga, Raluca Cursaru, Georgiana Enache, Adrian Costache, Ioana Verde, Andra Nica, Anca Alionescu, Florin Rusu, Gabriela Radulian Diabetology .2025

By concentrating on the distinct aging patterns of various organs, it is possible to create more focused biomarker panels that aid in both the analysis of biological age and the evaluation of treatment effectiveness

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may offer a safe and potentially beneficial option for managing obesity and metabolic comorbidities in adults with inflammatory bowel disease (IBD), according to a systematic review published in Alimentary Pharmacology & Therapeutics